HEPION PHARMACEUTICALS, INC. Interest Expense
HEPION PHARMACEUTICALS, INC. (HEPA) reported Interest Expense of $4.35 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-21.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-21
- HEPION PHARMACEUTICALS, INC. interest expense for the quarter ending 2024-03-31 was $4.35K, a 87.30% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-12-31 was $2.41K, a 4.02% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-09-30 was $2.38K, a 5.12% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-06-30 was $2.35K, a 26.02% decline year-over-year.
- HEPION PHARMACEUTICALS, INC. interest expense for fiscal 2023 was $9.46K, a 6.88% decline from fiscal 2022.
- HEPION PHARMACEUTICALS, INC. interest expense for fiscal 2022 was $10.16K, a 14.73% increase from fiscal 2021.
- HEPION PHARMACEUTICALS, INC. interest expense for fiscal 2021 was $8.86K, a 71.63% decline from fiscal 2020.
- HEPION PHARMACEUTICALS, INC. interest expense for fiscal 2020 was $31.23K, a 94.37% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $4.35K 10-Q · filed 2024-05-21 | $6.76K derived: sum of 2 quarters · filed 2024-05-21 | $9.14K derived: sum of 3 quarters · filed 2024-05-21 | $11.49K derived: sum of 4 quarters · filed 2024-05-21 |
| 2023-12-31 | $2.41K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $4.79K derived: sum of 2 quarters · filed 2024-04-16 | $7.14K derived: sum of 3 quarters · filed 2024-04-16 | $9.46K 10-K · filed 2024-04-16 |
| 2023-09-30 | $2.38K 10-Q · filed 2023-11-20 | $4.73K derived: sum of 2 quarters · filed 2023-11-20 | $7.05K 10-Q · filed 2023-11-20 | $9.57K derived: sum of 4 quarters · filed 2024-05-21 |
| 2023-06-30 | $2.35K 10-Q · filed 2023-08-14 | $4.67K 10-Q · filed 2023-08-14 | $7.18K derived: sum of 3 quarters · filed 2024-05-21 | $9.45K derived: sum of 4 quarters · filed 2024-05-21 |
| 2023-03-31 | $2.32K 10-Q · filed 2024-05-21 | $4.83K derived: sum of 2 quarters · filed 2024-05-21 | $7.10K derived: sum of 3 quarters · filed 2024-05-21 | $10.28K derived: sum of 4 quarters · filed 2024-05-21 |
| 2022-12-31 | $2.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $4.78K derived: sum of 2 quarters · filed 2024-04-16 | $7.96K derived: sum of 3 quarters · filed 2024-04-16 | $10.16K 10-K · filed 2024-04-16 |
| 2022-09-30 | $2.27K 10-Q · filed 2023-11-20 | $5.44K derived: sum of 2 quarters · filed 2023-11-20 | $7.65K 10-Q · filed 2023-11-20 | $9.83K derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-06-30 | $3.18K 10-Q · filed 2023-08-14 | $5.39K 10-Q · filed 2023-08-14 | $7.57K derived: sum of 3 quarters · filed 2023-08-14 | $9.70K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.21K 10-Q · filed 2023-05-12 | $4.39K derived: sum of 2 quarters · filed 2023-05-12 | $6.52K derived: sum of 3 quarters · filed 2023-05-12 | $9.01K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $2.18K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | $4.31K derived: sum of 2 quarters · filed 2023-04-10 | $6.80K derived: sum of 3 quarters · filed 2023-04-10 | $8.86K 10-K · filed 2023-04-10 |
| 2021-09-30 | $2.13K 10-Q · filed 2022-11-14 | $4.62K derived: sum of 2 quarters · filed 2022-11-14 | $6.68K 10-Q · filed 2022-11-14 | $21.75K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $2.49K 10-Q · filed 2022-08-15 | $4.55K 10-Q · filed 2022-08-15 | $19.62K derived: sum of 3 quarters · filed 2022-08-15 | $35.77K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $2.05K 10-Q · filed 2022-05-16 | $17.12K derived: sum of 2 quarters · filed 2022-05-16 | $33.28K derived: sum of 3 quarters · filed 2022-05-16 | $33.28K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $15.07K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $31.23K derived: sum of 2 quarters · filed 2022-04-08 | $31.23K derived: sum of 3 quarters · filed 2022-04-08 | $31.23K 10-K · filed 2022-04-08 |
| 2020-09-30 | $16.16K 10-Q · filed 2021-11-15 | $16.16K derived: sum of 2 quarters · filed 2021-11-15 | $16.16K 10-Q · filed 2021-11-15 | $15.72K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | -$443.00 derived: sum of 3 quarters · filed 2021-08-16 | $14.91K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | -$443.00 derived: sum of 2 quarters · filed 2021-05-14 | $14.91K derived: sum of 3 quarters · filed 2021-05-14 | $456.71K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$443.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $14.91K derived: sum of 2 quarters · filed 2021-03-31 | $456.71K derived: sum of 3 quarters · filed 2021-03-31 | $555.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $15.35K 10-Q · filed 2020-11-16 | $457.15K derived: sum of 2 quarters · filed 2020-11-16 | $555.44K 10-Q · filed 2020-11-16 | $607.19K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $441.80K 10-Q · filed 2020-08-12 | $540.09K 10-Q · filed 2020-08-12 | $591.84K derived: sum of 3 quarters · filed 2020-08-12 | $647.30K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $98.29K 10-Q · filed 2020-06-29 | $150.04K derived: sum of 2 quarters · filed 2020-06-29 | $205.50K derived: sum of 3 quarters · filed 2020-06-29 | $437.44K derived: sum of 4 quarters · filed 2020-06-29 |
| 2018-12-31 | $51.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | $107.21K derived: sum of 2 quarters · filed 2020-05-14 | $339.16K derived: sum of 3 quarters · filed 2020-05-14 | $339.16K 10-K · filed 2020-05-14 |
| 2018-09-30 | $55.46K 10-Q · filed 2018-11-14 | $287.41K derived: sum of 2 quarters · filed 2018-11-14 | $287.41K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $231.95K 10-Q · filed 2018-08-14 | $231.95K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |